PTGS2 and COVID-19: Evidence from acute COVID-19 indicates that the SARS-CoV-2 virus can trigger a prostaglandin E2 (PGE2) storm in a substantial proportion of patients via upregulating cyclooxygenase-2 (COX-2) and downregulating PGE2-degrading enzymes within host cells.